Speed Dating, BIO-Style | GenomeWeb

Fortune's David Ewing Duncan asks whether a "marriage between pharma and biotech will create more drugs." Pharmaceutical companies, he notes, "are struggling to replenish research development pipelines," whereas biotech firms "have the best ideas for new drugs but are constantly short of cash." But as of the Biotechnology Industry Organization meeting in Chicago last week, he says, the two are coming together.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Lots to Do

To Catch a Cheat

Good for a Brew

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.